A detailed history of Harbour Investments, Inc. transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 13 shares of ONVO stock, worth $4. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$4
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.64 - $2.24 $180 - $246
-110 Reduced 89.43%
13 $0
Q2 2022

Aug 15, 2022

SELL
$1.71 - $3.71 $35 - $77
-21 Reduced 14.58%
123 $0
Q4 2021

Feb 16, 2022

SELL
$3.63 - $6.86 $1,978 - $3,738
-545 Reduced 79.1%
144 $1,000
Q2 2021

Aug 16, 2021

BUY
$6.65 - $9.95 $86 - $129
13 Added 1.92%
689 $6,000
Q1 2021

Aug 17, 2021

BUY
$8.67 - $21.7 $5,774 - $14,452
666 Added 6660.0%
676 $7,000
Q1 2021

May 12, 2021

BUY
$8.67 - $21.7 $86 - $217
10 New
10 $0

Others Institutions Holding ONVO

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $3.22M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.